methylphenidate has been researched along with Disease Exacerbation in 8 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Psychiatrists treated major depressive disorder in advanced cancer patients on the basis of the algorithm." | 1.35 | Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer. ( Akechi, T; Akizuki, N; Ito, T; Nakano, T; Okamura, M; Shimizu, K; Uchitomi, Y, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Rodríguez Hernández, PJ | 1 |
| Betancort Montesinos, M | 1 |
| Peñate Castro, W | 1 |
| Semeijn, EJ | 1 |
| Sandra Kooij, JJ | 1 |
| Comijs, HC | 1 |
| Michielsen, M | 1 |
| Deeg, DJH | 1 |
| Beekman, ATF | 1 |
| Tarver, J | 1 |
| Daley, D | 1 |
| Sayal, K | 1 |
| Mamey, MR | 1 |
| Barbosa-Leiker, C | 1 |
| McPherson, S | 1 |
| Burns, GL | 1 |
| Parks, C | 1 |
| Roll, J | 1 |
| de la Fuente-Fernández, R | 1 |
| Schulzer, M | 1 |
| Kuramoto, L | 1 |
| Cragg, J | 1 |
| Ramachandiran, N | 1 |
| Au, WL | 1 |
| Mak, E | 1 |
| McKenzie, J | 1 |
| McCormick, S | 1 |
| Sossi, V | 1 |
| Ruth, TJ | 1 |
| Lee, CS | 1 |
| Calne, DB | 1 |
| Stoessl, AJ | 1 |
| Gray, KM | 1 |
| Riggs, PD | 1 |
| Min, SJ | 1 |
| Mikulich-Gilbertson, SK | 1 |
| Bandyopadhyay, D | 1 |
| Winhusen, T | 1 |
| Okamura, M | 1 |
| Akizuki, N | 1 |
| Nakano, T | 1 |
| Shimizu, K | 1 |
| Ito, T | 1 |
| Akechi, T | 1 |
| Uchitomi, Y | 1 |
| Goodman, DW | 1 |
2 reviews available for methylphenidate and Disease Exacerbation
| Article | Year |
|---|---|
Attention-deficit hyperactivity disorder (ADHD): an updated review of the essential facts.
Topics: Attention Deficit Disorder with Hyperactivity; Brain; Child; Child Behavior Disorders; Child Develop | 2014 |
The consequences of attention-deficit/hyperactivity disorder in adults.
Topics: Achievement; Adult; Age Factors; Amphetamine; Atomoxetine Hydrochloride; Attention Deficit Disorder | 2007 |
2 trials available for methylphenidate and Disease Exacerbation
| Article | Year |
|---|---|
An application of analyzing the trajectories of two disorders: A parallel piecewise growth model of substance use and attention-deficit/hyperactivity disorder.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cognit | 2015 |
Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders.
Topics: Administration, Oral; Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous Sys | 2011 |
4 other studies available for methylphenidate and Disease Exacerbation
| Article | Year |
|---|---|
[Progression of symptoms in children with attention deficit and hyperactivity disorder in treatment with methylphenidate].
Topics: Attention Deficit Disorder with Hyperactivity; Child; Disease Progression; Dopamine Uptake Inhibitor | 2020 |
Attention-deficit/hyperactivity disorder, physical health, and lifestyle in older adults.
Topics: Aged; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; D | 2013 |
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Topics: Adult; Aged; Aging; Carbon Isotopes; Corpus Striatum; Disease Progression; Female; Fluorodeoxyglucos | 2011 |
Clinical experience of the use of a pharmacological treatment algorithm for major depressive disorder in patients with advanced cancer.
Topics: Adult; Aged; Algorithms; Alprazolam; Amitriptyline; Antidepressive Agents; Anxiety Disorders; Benzod | 2008 |